<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00580788</url>
  </required_header>
  <id_info>
    <org_study_id>PRO07040081</org_study_id>
    <secondary_id>R01DK073039</secondary_id>
    <nct_id>NCT00580788</nct_id>
  </id_info>
  <brief_title>One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study</brief_title>
  <official_title>Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone-related Protein(1-36): Effects on Bone Formation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a dose escalation study to determine the maximum tolerable dose of Parathyroid
      Hormone-related Protein, PTHrP, that can be given safely over one week. The investigators
      plan to infuse low doses of intravenous PTHrP to determine if it leads to a sustained and
      progressive suppression of bone formation as occurs in humoral hypercalcemia of malignancy
      (HHM) or an increase in bone formation as occurs in hyperparathyroidism (HPT). Additionally,
      the investigators will assess the direct influence of PTHrp on markers of bone turnover, and
      plasma 1,25 (OH)2 vitamin D regulation in healthy human volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During this research the investigators administer PTHrP to healthy young volunteers in a
      controlled, continuous intravenous manner. As research subjects complete the week-long study
      without adverse effects, the dose of PThrP will be increased in later subjects. In the event
      of a significant adverse effect, immediate action will be taken to reverse it. The
      investigators want to estimate the effect of a sustainable level of mild hypercalcemia
      achieved by a week-long intravenous infusion of PTHrP has on vitamin D metabolism, markers of
      bone turnover and fractional excretion of calcium.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dose Limiting Toxicity (DLT)</measure>
    <time_frame>12 hours after the infusion was started then q 8 hours for 7 days</time_frame>
    <description>DLT was defined as achieving one major criterion or two minor criteria rated at ≥ 2 on a scale of 0-5. The major criteria were defined as symptomatic orthostatic hypotension (systolic BP fall &gt;30 mm/hg), tachycardia (pulse &gt; 120), hypertension (systolic BP &gt;160 mm/hg on 2 occasions), hypercalcemia (serum calcium ≥ 12 mg/dl), and hypophosphatemia (serum phosphorous &lt; 1.5 mg/dl). Minor criteria included symptoms such as flushing, nausea, abdominal or muscle cramps, dizziness, lightheadedness, palpitations, etc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Serum Calcium</measure>
    <time_frame>12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete</time_frame>
    <description>mg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ionized Serum Calcium</measure>
    <time_frame>12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete</time_frame>
    <description>mg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Phosphorous</measure>
    <time_frame>12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete</time_frame>
    <description>mg/dl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1,25 Vitamin D</measure>
    <time_frame>Baseline and Daily through day 8 then at follow-up visit</time_frame>
    <description>pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 Hour Urine Calcium</measure>
    <time_frame>24 hours</time_frame>
    <description>mg/gm creatinine collected on day 7 of PTHrP infusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tubular Maximum of Phosphorous (TmP/GFR)</measure>
    <time_frame>daily</time_frame>
    <description>mg/dl calculated from daily second morning void</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Amino-terminal Telopeptide of Collagen -1 (sNTX)</measure>
    <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
    <description>% change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX)</measure>
    <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
    <description>% change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amino-terminal Peptides of Procollagen 1 (P1NP)</measure>
    <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
    <description>% change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone Specific Alkaline Phosphatase (BSAP)</measure>
    <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
    <description>% change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parathyroid Hormone (1-84)</measure>
    <time_frame>Baseline and Daily</time_frame>
    <description>pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional Excretion of Calcium</measure>
    <time_frame>daily</time_frame>
    <description>% calculated from daily second morning void</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Humoral Hypercalcemia of Malignancy</condition>
  <condition>Hyperparathyroidism</condition>
  <arm_group>
    <arm_group_label>PTHrP(1-36) 2 pmol/kg/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PTHrP(1-36) at 2 picomoles/kg/hr for one week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PTHrP (1-36) 4 pmol/kg/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PTHrP(1-36) at 4 picomoles/kg/hr for one week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PTHrP(1-36) 5 pmol/kg/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PTHrP(1-36) at 5 picomoles/kg/hr for one week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PTHrP(1-36) 6 pmol/kg/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PTHrP(1-36) at 6 picomoles/kg/hr for one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PTHrP (1-36)</intervention_name>
    <description>IND # 49,175</description>
    <arm_group_label>PTHrP(1-36) 2 pmol/kg/hr</arm_group_label>
    <arm_group_label>PTHrP (1-36) 4 pmol/kg/hr</arm_group_label>
    <arm_group_label>PTHrP(1-36) 5 pmol/kg/hr</arm_group_label>
    <arm_group_label>PTHrP(1-36) 6 pmol/kg/hr</arm_group_label>
    <other_name>Parathyroid Hormone-related Protein (1-36)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy caucasian subjects of both sexes between the ages of 24-35 years, who are able
             to spend one week on the Clinical &amp; Translational Research Center at the University of
             Pittsburgh Medical Center (UPMC) Montefiore

        Exclusion Criteria:

          -  Pregnancy

          -  Any cardiac, renal, pulmonary, endocrine, musculoskeletal, hepatic, hematological,
             malignant or rheumatologic diseases

          -  Body mass index great than 30

          -  Anemia

          -  Significant alcohol or drug abuse

          -  Baseline hypotension or hypertension

          -  Abnormal screening labs

          -  Use of certain chronic medications excluding oral contraceptives

          -  Receiving an investigational drug in the last 90 days

          -  Previously receiving PTH or PTHrP

          -  African-American race
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mara J Horwitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Jüppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg HM, et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 1991 Nov 15;254(5034):1024-6.</citation>
    <PMID>1658941</PMID>
  </reference>
  <reference>
    <citation>Orloff JJ, Wu TL, Heath HW, Brady TG, Brines ML, Stewart AF. Characterization of canine renal receptors for the parathyroid hormone-like protein associated with humoral hypercalcemia of malignancy. J Biol Chem. 1989 Apr 15;264(11):6097-103.</citation>
    <PMID>2539369</PMID>
  </reference>
  <reference>
    <citation>Orloff JJ, Ribaudo AE, McKee RL, Rosenblatt M, Stewart AF. A pharmacological comparison of parathyroid hormone receptors in human bone and kidney. Endocrinology. 1992 Oct;131(4):1603-11.</citation>
    <PMID>1327716</PMID>
  </reference>
  <reference>
    <citation>Orloff JJ, Reddy D, de Papp AE, Yang KH, Soifer NE, Stewart AF. Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev. 1994 Feb;15(1):40-60. Review.</citation>
    <PMID>8156938</PMID>
  </reference>
  <reference>
    <citation>Samuels MH, Veldhuis J, Cawley C, Urban RJ, Luther M, Bauer R, Mundy G. Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis. J Clin Endocrinol Metab. 1993 Aug;77(2):399-403.</citation>
    <PMID>8345044</PMID>
  </reference>
  <reference>
    <citation>Prank K, Nowlan SJ, Harms HM, Kloppstech M, Brabant G, Hesch RD, Sejnowski TJ. Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls. J Clin Invest. 1995 Jun;95(6):2910-9.</citation>
    <PMID>7769133</PMID>
  </reference>
  <reference>
    <citation>Schmitt CP, Obry J, Feneberg R, Veldhuis JD, Mehls O, Ritz E, Schaefer F. Beta1-adrenergic blockade augments pulsatile PTH secretion in humans. J Am Soc Nephrol. 2003 Dec;14(12):3245-50.</citation>
    <PMID>14638923</PMID>
  </reference>
  <reference>
    <citation>Chapotot F, Gronfier C, Spiegel K, Luthringer R, Brandenberger G. Relationships between intact parathyroid hormone 24-hour profiles, sleep-wake cycle, and sleep electroencephalographic activity in man. J Clin Endocrinol Metab. 1996 Oct;81(10):3759-65.</citation>
    <PMID>8855835</PMID>
  </reference>
  <reference>
    <citation>Harms HM, Schlinke E, Neubauer O, Kayser C, Wüstermann PR, Horn R, Külpmann WR, von zur Mühlen A, Hesch RD. Pulse amplitude and frequency modulation of parathyroid hormone in primary hyperparathyroidism. J Clin Endocrinol Metab. 1994 Jan;78(1):53-7.</citation>
    <PMID>8288713</PMID>
  </reference>
  <reference>
    <citation>Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab. 1995 Nov;80(11):3304-10.</citation>
    <PMID>7593443</PMID>
  </reference>
  <reference>
    <citation>el-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA. The parathyroid hormone circadian rhythm is truly endogenous--a general clinical research center study. J Clin Endocrinol Metab. 1997 Jan;82(1):281-6.</citation>
    <PMID>8989274</PMID>
  </reference>
  <reference>
    <citation>Plawner LL, Philbrick WM, Burtis WJ, Broadus AE, Stewart AF. Cell type-specific secretion of parathyroid hormone-related protein via the regulated versus the constitutive secretory pathway. J Biol Chem. 1995 Jun 9;270(23):14078-84.</citation>
    <PMID>7775469</PMID>
  </reference>
  <reference>
    <citation>Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab. 2003 Apr;88(4):1603-9.</citation>
    <PMID>12679445</PMID>
  </reference>
  <reference>
    <citation>Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocaña A, Wisniewski SR, Stewart AF. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. J Clin Endocrinol Metab. 2001 Apr;86(4):1525-31.</citation>
    <PMID>11297578</PMID>
  </reference>
  <reference>
    <citation>Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick MA, Stewart AF. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans. J Clin Endocrinol Metab. 1996 Jan;81(1):199-208.</citation>
    <PMID>8550752</PMID>
  </reference>
  <reference>
    <citation>Fraher LJ, Hodsman AB, Jonas K, Saunders D, Rose CI, Henderson JE, Hendy GN, Goltzman D. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J Clin Endocrinol Metab. 1992 Aug;75(2):417-23.</citation>
    <PMID>1322424</PMID>
  </reference>
  <reference>
    <citation>Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocaña A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. J Bone Miner Res. 2005 Oct;20(10):1792-803. Epub 2005 Jun 6.</citation>
    <PMID>16160737</PMID>
  </reference>
  <reference>
    <citation>Horwitz MJ, Tedesco MB, Sereika SM, Garcia-Ocaña A, Bisello A, Hollis BW, Gundberg C, Stewart AF. Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study. Osteoporos Int. 2006 Feb;17(2):225-30. Epub 2005 Sep 7.</citation>
    <PMID>16151606</PMID>
  </reference>
  <reference>
    <citation>Plotkin H, Gundberg C, Mitnick M, Stewart AF. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis. J Clin Endocrinol Metab. 1998 Aug;83(8):2786-91.</citation>
    <PMID>9709948</PMID>
  </reference>
  <reference>
    <citation>Stewart AF, Mangin M, Wu T, Goumas D, Insogna KL, Burtis WJ, Broadus AE. Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats. J Clin Invest. 1988 Feb;81(2):596-600.</citation>
    <PMID>3339131</PMID>
  </reference>
  <reference>
    <citation>Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, Stewart AF. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem. 1987 May 25;262(15):7151-6.</citation>
    <PMID>3584110</PMID>
  </reference>
  <reference>
    <citation>Stewart AF, Wu T, Goumas D, Burtis WJ, Broadus AE. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun. 1987 Jul 31;146(2):672-8.</citation>
    <PMID>3619898</PMID>
  </reference>
  <reference>
    <citation>Wu TL, Vasavada RC, Yang K, Massfelder T, Ganz M, Abbas SK, Care AD, Stewart AF. Structural and physiologic characterization of the mid-region secretory species of parathyroid hormone-related protein. J Biol Chem. 1996 Oct 4;271(40):24371-81.</citation>
    <PMID>8798692</PMID>
  </reference>
  <reference>
    <citation>Cosman F, Shen V, Xie F, Seibel M, Ratcliffe A, Lindsay R. Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers. Ann Intern Med. 1993 Mar 1;118(5):337-43. Erratum in: Ann Intern Med 1994 Apr 15;120(8):698.</citation>
    <PMID>8430979</PMID>
  </reference>
  <reference>
    <citation>Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest. 1993 Mar;91(3):1138-48.</citation>
    <PMID>8450043</PMID>
  </reference>
  <reference>
    <citation>Fiaschi-Taesch NM, Stewart AF. Minireview: parathyroid hormone-related protein as an intracrine factor--trafficking mechanisms and functional consequences. Endocrinology. 2003 Feb;144(2):407-11. Review.</citation>
    <PMID>12538599</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2007</study_first_submitted>
  <study_first_submitted_qc>December 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2007</study_first_posted>
  <results_first_submitted>April 25, 2014</results_first_submitted>
  <results_first_submitted_qc>February 9, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 11, 2016</results_first_posted>
  <last_update_submitted>February 9, 2016</last_update_submitted>
  <last_update_submitted_qc>February 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Mara Horwitz</investigator_full_name>
    <investigator_title>Associate Professor of Medicne</investigator_title>
  </responsible_party>
  <keyword>Endocrine System Diseases</keyword>
  <keyword>MusculoSkeletal System Diseases</keyword>
  <keyword>Hormones</keyword>
  <keyword>Malignancy</keyword>
  <keyword>Postmenopausal Women</keyword>
  <keyword>Bone metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Hypercalcemia</mesh_term>
    <mesh_term>Paraneoplastic Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>24 subjects were screened and 14 were randomized in the study. Data from 2 subjects was not included in the analysis as there were not enough subjects in that group for analysis. 12 subjects were analyzed.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Group 1</title>
          <description>PTHrP(1-36) 2 picomoles/kg/hr</description>
        </group>
        <group group_id="P2">
          <title>Group 2</title>
          <description>PTHrP(1-36) 4 picomoles/kg/hr</description>
        </group>
        <group group_id="P3">
          <title>Group 3</title>
          <description>PTHrP (1-36) 5 pmol/kg/hr</description>
        </group>
        <group group_id="P4">
          <title>Group 4</title>
          <description>PTHrP (1-36) 6 picomoles/kg/hr</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="1">One subject was stopped early for hypertension. One subject completed but was not analyzed.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1</title>
          <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
        </group>
        <group group_id="B2">
          <title>Group 2</title>
          <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
        </group>
        <group group_id="B3">
          <title>Group 3</title>
          <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
        </group>
        <group group_id="B4">
          <title>Group 4</title>
          <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="3"/>
            <count group_id="B4" value="2"/>
            <count group_id="B5" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Dose Limiting Toxicity (DLT)</title>
        <description>DLT was defined as achieving one major criterion or two minor criteria rated at ≥ 2 on a scale of 0-5. The major criteria were defined as symptomatic orthostatic hypotension (systolic BP fall &gt;30 mm/hg), tachycardia (pulse &gt; 120), hypertension (systolic BP &gt;160 mm/hg on 2 occasions), hypercalcemia (serum calcium ≥ 12 mg/dl), and hypophosphatemia (serum phosphorous &lt; 1.5 mg/dl). Minor criteria included symptoms such as flushing, nausea, abdominal or muscle cramps, dizziness, lightheadedness, palpitations, etc.</description>
        <time_frame>12 hours after the infusion was started then q 8 hours for 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Dose Limiting Toxicity (DLT)</title>
          <description>DLT was defined as achieving one major criterion or two minor criteria rated at ≥ 2 on a scale of 0-5. The major criteria were defined as symptomatic orthostatic hypotension (systolic BP fall &gt;30 mm/hg), tachycardia (pulse &gt; 120), hypertension (systolic BP &gt;160 mm/hg on 2 occasions), hypercalcemia (serum calcium ≥ 12 mg/dl), and hypophosphatemia (serum phosphorous &lt; 1.5 mg/dl). Minor criteria included symptoms such as flushing, nausea, abdominal or muscle cramps, dizziness, lightheadedness, palpitations, etc.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1,25 Vitamin D</title>
        <description>pg/ml</description>
        <time_frame>Baseline and Daily through day 8 then at follow-up visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>1,25 Vitamin D</title>
          <description>pg/ml</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.13" spread="3.03"/>
                    <measurement group_id="O2" value="45.08" spread="4.24"/>
                    <measurement group_id="O3" value="39.0" spread="4.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.40" spread="5.12"/>
                    <measurement group_id="O2" value="45.88" spread="1.53"/>
                    <measurement group_id="O3" value="39.77" spread="2.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.13" spread="4.57"/>
                    <measurement group_id="O2" value="36.58" spread="4.17"/>
                    <measurement group_id="O3" value="36.73" spread="2.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.23" spread="2.32"/>
                    <measurement group_id="O2" value="40.38" spread="4.18"/>
                    <measurement group_id="O3" value="35.17" spread="2.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.27" spread="1.80"/>
                    <measurement group_id="O2" value="46.40" spread="6.12"/>
                    <measurement group_id="O3" value="32.07" spread="3.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.77" spread="4.23"/>
                    <measurement group_id="O2" value="34.90" spread="4.91"/>
                    <measurement group_id="O3" value="35.37" spread="2.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.53" spread="4.38"/>
                    <measurement group_id="O2" value="37.12" spread="3.58"/>
                    <measurement group_id="O3" value="31.17" spread="6.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.37" spread="3.17"/>
                    <measurement group_id="O2" value="33.43" spread="3.13"/>
                    <measurement group_id="O3" value="30.63" spread="4.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.10" spread="4.01"/>
                    <measurement group_id="O2" value="45.78" spread="4.72"/>
                    <measurement group_id="O3" value="36.33" spread="2.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The reported p-value corresponds to change over time for the PTHrP 2 and PTHrP 5 pmol groups</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>0.01</p_value>
            <p_value_desc>the reported p value corresponds to a decrease by Day 8 compared to baseline in the PTHrP 4 pmol group</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24 Hour Urine Calcium</title>
        <description>mg/gm creatinine collected on day 7 of PTHrP infusion</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week</description>
          </group>
        </group_list>
        <measure>
          <title>24 Hour Urine Calcium</title>
          <description>mg/gm creatinine collected on day 7 of PTHrP infusion</description>
          <units>mg/gm creatinine</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.64" spread="9.87"/>
                    <measurement group_id="O2" value="283.43" spread="30.93"/>
                    <measurement group_id="O3" value="320.23" spread="41.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tubular Maximum of Phosphorous (TmP/GFR)</title>
        <description>mg/dl calculated from daily second morning void</description>
        <time_frame>daily</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Tubular Maximum of Phosphorous (TmP/GFR)</title>
          <description>mg/dl calculated from daily second morning void</description>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.43" spread="0.26"/>
                    <measurement group_id="O2" value="3.91" spread="0.23"/>
                    <measurement group_id="O3" value="3.38" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.48" spread="0.20"/>
                    <measurement group_id="O2" value="4.08" spread="0.23"/>
                    <measurement group_id="O3" value="3.47" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.28" spread="0.30"/>
                    <measurement group_id="O2" value="3.74" spread="0.26"/>
                    <measurement group_id="O3" value="3.25" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.42" spread="0.31"/>
                    <measurement group_id="O2" value="3.75" spread="0.31"/>
                    <measurement group_id="O3" value="3.15" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.43" spread="0.02"/>
                    <measurement group_id="O2" value="3.95" spread="0.34"/>
                    <measurement group_id="O3" value="3.37" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.90" spread="0.08"/>
                    <measurement group_id="O2" value="3.98" spread="0.11"/>
                    <measurement group_id="O3" value="3.38" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.15" spread="0.08"/>
                    <measurement group_id="O2" value="3.98" spread="0.19"/>
                    <measurement group_id="O3" value="2.95" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>0.61</p_value>
            <p_value_desc>The reported p-value corresponds to all Arms/Groups at all time points compared to baseline</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Serum Calcium</title>
        <description>mg/dl</description>
        <time_frame>12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP (1-36) 5 pmol/kg/hr</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP (1-36) 6 picomoles/kg/hr</description>
          </group>
        </group_list>
        <measure>
          <title>Total Serum Calcium</title>
          <description>mg/dl</description>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.37" spread="0.07"/>
                    <measurement group_id="O2" value="9.58" spread="0.12"/>
                    <measurement group_id="O3" value="9.2" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.67" spread="0.09"/>
                    <measurement group_id="O2" value="9.80" spread="0.16"/>
                    <measurement group_id="O3" value="9.67" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="0.17"/>
                    <measurement group_id="O2" value="10.05" spread="0.19"/>
                    <measurement group_id="O3" value="10.17" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.57" spread="0.09"/>
                    <measurement group_id="O2" value="10.28" spread="0.14"/>
                    <measurement group_id="O3" value="10.47" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.67" spread="0.09"/>
                    <measurement group_id="O2" value="10.32" spread="0.14"/>
                    <measurement group_id="O3" value="10.23" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.6" spread="0.10"/>
                    <measurement group_id="O2" value="10.40" spread="0.18"/>
                    <measurement group_id="O3" value="10.73" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.73" spread="0.09"/>
                    <measurement group_id="O2" value="10.42" spread="0.14"/>
                    <measurement group_id="O3" value="10.67" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.40" spread="0.17"/>
                    <measurement group_id="O2" value="9.73" spread="0.10"/>
                    <measurement group_id="O3" value="9.93" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.47" spread="0.03"/>
                    <measurement group_id="O2" value="10.00" spread="0.24"/>
                    <measurement group_id="O3" value="10.3" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.40" spread="0.17"/>
                    <measurement group_id="O2" value="9.92" spread="0.21"/>
                    <measurement group_id="O3" value="10.33" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.37" spread="0.09"/>
                    <measurement group_id="O2" value="9.48" spread="0.11"/>
                    <measurement group_id="O3" value="10.00" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.30" spread="0.12"/>
                    <measurement group_id="O2" value="9.62" spread="0.12"/>
                    <measurement group_id="O3" value="10.53" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.50" spread="0.15"/>
                    <measurement group_id="O2" value="9.83" spread="0.20"/>
                    <measurement group_id="O3" value="10.27" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.43" spread="0.09"/>
                    <measurement group_id="O2" value="9.45" spread="0.13"/>
                    <measurement group_id="O3" value="9.80" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.57" spread="0.07"/>
                    <measurement group_id="O2" value="9.83" spread="0.20"/>
                    <measurement group_id="O3" value="10.53" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.43" spread="0.15"/>
                    <measurement group_id="O2" value="10.08" spread="0.12"/>
                    <measurement group_id="O3" value="10.83" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.43" spread="0.13"/>
                    <measurement group_id="O2" value="9.67" spread="0.21"/>
                    <measurement group_id="O3" value="10.43" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.40" spread="0.10"/>
                    <measurement group_id="O2" value="10.13" spread="0.28"/>
                    <measurement group_id="O3" value="10.90" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.70" spread="0.15"/>
                    <measurement group_id="O2" value="10.22" spread="0.32"/>
                    <measurement group_id="O3" value="10.70" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.60" spread="0.15"/>
                    <measurement group_id="O2" value="10.27" spread="0.28"/>
                    <measurement group_id="O3" value="10.73" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.83" spread="0.13"/>
                    <measurement group_id="O2" value="10.67" spread="0.40"/>
                    <measurement group_id="O3" value="11.17" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FOLLOW-UP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.33" spread="0.07"/>
                    <measurement group_id="O2" value="9.80" spread="0.12"/>
                    <measurement group_id="O3" value="9.17" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>The reported p-value corresponds to the increase over time for the PTHrP 4 pmol group.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Value The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ionized Serum Calcium</title>
        <description>mg/dl</description>
        <time_frame>12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP (1-36) 5 pmol/kg/hr</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP (1-36) 6 picomoles/kg/hr</description>
          </group>
        </group_list>
        <measure>
          <title>Ionized Serum Calcium</title>
          <description>mg/dl</description>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.79" spread="0.03"/>
                    <measurement group_id="O2" value="4.72" spread="0.08"/>
                    <measurement group_id="O3" value="4.55" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.51" spread="0.05"/>
                    <measurement group_id="O2" value="4.77" spread="0.08"/>
                    <measurement group_id="O3" value="4.75" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.77" spread="0.07"/>
                    <measurement group_id="O2" value="4.98" spread="0.10"/>
                    <measurement group_id="O3" value="5.07" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.52" spread="0.02"/>
                    <measurement group_id="O2" value="4.99" spread="0.06"/>
                    <measurement group_id="O3" value="5.07" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.48" spread="0.08"/>
                    <measurement group_id="O2" value="5.04" spread="0.07"/>
                    <measurement group_id="O3" value="4.84" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.77" spread="0.15"/>
                    <measurement group_id="O2" value="5.31" spread="0.08"/>
                    <measurement group_id="O3" value="5.25" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.73" spread="0.11"/>
                    <measurement group_id="O2" value="4.99" spread="0.10"/>
                    <measurement group_id="O3" value="4.91" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.41" spread="0.15"/>
                    <measurement group_id="O2" value="4.58" spread="0.15"/>
                    <measurement group_id="O3" value="4.83" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.75" spread="0.14"/>
                    <measurement group_id="O2" value="4.90" spread="0.13"/>
                    <measurement group_id="O3" value="5.11" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.45" spread="0.16"/>
                    <measurement group_id="O2" value="4.68" spread="0.14"/>
                    <measurement group_id="O3" value="4.72" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.47" spread="0.07"/>
                    <measurement group_id="O2" value="4.46" spread="0.12"/>
                    <measurement group_id="O3" value="4.69" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.71" spread="0.07"/>
                    <measurement group_id="O2" value="4.82" spread="0.09"/>
                    <measurement group_id="O3" value="4.97" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.61" spread="0.20"/>
                    <measurement group_id="O2" value="4.67" spread="0.12"/>
                    <measurement group_id="O3" value="4.87" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.60" spread="0.13"/>
                    <measurement group_id="O2" value="4.58" spread="0.07"/>
                    <measurement group_id="O3" value="4.79" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.63" spread="0.03"/>
                    <measurement group_id="O2" value="4.77" spread="0.10"/>
                    <measurement group_id="O3" value="5.25" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.72" spread="0.13"/>
                    <measurement group_id="O2" value="4.83" spread="0.07"/>
                    <measurement group_id="O3" value="5.35" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.32" spread="0.06"/>
                    <measurement group_id="O2" value="4.72" spread="0.09"/>
                    <measurement group_id="O3" value="5.19" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.55" spread="0.22"/>
                    <measurement group_id="O2" value="5.01" spread="0.09"/>
                    <measurement group_id="O3" value="5.55" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.84" spread="0.16"/>
                    <measurement group_id="O2" value="5.04" spread="0.17"/>
                    <measurement group_id="O3" value="5.25" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.56" spread="0.12"/>
                    <measurement group_id="O2" value="4.87" spread="0.19"/>
                    <measurement group_id="O3" value="5.24" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.00" spread="0.11"/>
                    <measurement group_id="O2" value="5.43" spread="0.18"/>
                    <measurement group_id="O3" value="5.69" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FOLLOW-UP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.68" spread="0.08"/>
                    <measurement group_id="O2" value="4.83" spread="0.05"/>
                    <measurement group_id="O3" value="4.80" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>The reported p-value corresponds to the increase over time for the PTHrP 4 pmol group.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serum Phosphorous</title>
        <description>mg/dl</description>
        <time_frame>12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP (1-36) 5 pmol/kg/hr</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP (1-36) 6 picomoles/kg/hr</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Phosphorous</title>
          <description>mg/dl</description>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.55" spread="0.15"/>
                    <measurement group_id="O2" value="3.63" spread="0.14"/>
                    <measurement group_id="O3" value="3.55" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.87" spread="0.26"/>
                    <measurement group_id="O2" value="3.90" spread="0.16"/>
                    <measurement group_id="O3" value="4.03" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.07" spread="0.15"/>
                    <measurement group_id="O2" value="4.20" spread="0.15"/>
                    <measurement group_id="O3" value="3.63" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.63" spread="0.33"/>
                    <measurement group_id="O2" value="3.50" spread="0.23"/>
                    <measurement group_id="O3" value="3.70" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.13" spread="0.29"/>
                    <measurement group_id="O2" value="3.52" spread="0.19"/>
                    <measurement group_id="O3" value="3.63" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.90" spread="0.26"/>
                    <measurement group_id="O2" value="3.77" spread="0.19"/>
                    <measurement group_id="O3" value="3.43" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.53" spread="0.24"/>
                    <measurement group_id="O2" value="3.53" spread="0.18"/>
                    <measurement group_id="O3" value="3.60" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.03" spread="0.26"/>
                    <measurement group_id="O2" value="3.58" spread="0.17"/>
                    <measurement group_id="O3" value="3.70" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.07" spread="0.22"/>
                    <measurement group_id="O2" value="3.90" spread="0.13"/>
                    <measurement group_id="O3" value="3.30" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.90" spread="0.10"/>
                    <measurement group_id="O2" value="3.37" spread="0.20"/>
                    <measurement group_id="O3" value="3.33" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.67" spread="0.28"/>
                    <measurement group_id="O2" value="3.48" spread="0.14"/>
                    <measurement group_id="O3" value="3.63" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.87" spread="0.19"/>
                    <measurement group_id="O2" value="4.02" spread="0.14"/>
                    <measurement group_id="O3" value="3.20" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.57" spread="0.29"/>
                    <measurement group_id="O2" value="3.35" spread="0.20"/>
                    <measurement group_id="O3" value="3.10" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.93" spread="0.23"/>
                    <measurement group_id="O2" value="3.45" spread="0.20"/>
                    <measurement group_id="O3" value="3.87" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.00" spread="0.06"/>
                    <measurement group_id="O2" value="4.00" spread="0.10"/>
                    <measurement group_id="O3" value="3.63" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.67" spread="0.03"/>
                    <measurement group_id="O2" value="3.80" spread="0.14"/>
                    <measurement group_id="O3" value="3.73" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.93" spread="0.18"/>
                    <measurement group_id="O2" value="3.90" spread="0.10"/>
                    <measurement group_id="O3" value="3.93" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.30" spread="0.10"/>
                    <measurement group_id="O2" value="4.28" spread="0.12"/>
                    <measurement group_id="O3" value="3.73" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3P DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.07" spread="0.09"/>
                    <measurement group_id="O2" value="3.62" spread="0.20"/>
                    <measurement group_id="O3" value="3.50" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11P DAY 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.20" spread="0.26"/>
                    <measurement group_id="O2" value="3.62" spread="0.19"/>
                    <measurement group_id="O3" value="3.60" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7A DAY 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.43" spread="0.15"/>
                    <measurement group_id="O2" value="4.10" spread="0.10"/>
                    <measurement group_id="O3" value="3.40" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FOLLOW-UP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.57" spread="0.38"/>
                    <measurement group_id="O2" value="3.48" spread="0.26"/>
                    <measurement group_id="O3" value="3.87" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&gt;.05</p_value>
            <p_value_desc>The reported p-value corresponds to change over time from baseline for all Arms/groups</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Amino-terminal Telopeptide of Collagen -1 (sNTX)</title>
        <description>% change from baseline</description>
        <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Amino-terminal Telopeptide of Collagen -1 (sNTX)</title>
          <description>% change from baseline</description>
          <units>% change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.86" spread="23.41"/>
                    <measurement group_id="O2" value="87.75" spread="18.79"/>
                    <measurement group_id="O3" value="54.21" spread="10.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.73" spread="23.19"/>
                    <measurement group_id="O2" value="91.53" spread="28.94"/>
                    <measurement group_id="O3" value="88.51" spread="19.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.32" spread="20.26"/>
                    <measurement group_id="O2" value="90.86" spread="32.25"/>
                    <measurement group_id="O3" value="89.57" spread="20.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.29" spread="20.06"/>
                    <measurement group_id="O2" value="82.36" spread="20.62"/>
                    <measurement group_id="O3" value="116.58" spread="13.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.41" spread="12.63"/>
                    <measurement group_id="O2" value="123.08" spread="28.62"/>
                    <measurement group_id="O3" value="150.82" spread="48.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.04" spread="21.44"/>
                    <measurement group_id="O2" value="161.55" spread="41.54"/>
                    <measurement group_id="O3" value="176.42" spread="50.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.77" spread="30.43"/>
                    <measurement group_id="O2" value="214.90" spread="59.26"/>
                    <measurement group_id="O3" value="108.69" spread="34.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.95" spread="2.97"/>
                    <measurement group_id="O2" value="-3.33" spread="6.68"/>
                    <measurement group_id="O3" value="-9.02" spread="7.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&lt;.008</p_value>
            <p_value_desc>The reported p-value corresponds to the % increase compared to baseline in all Arms/groups on Days 2-8.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The reported p-value corresponds the the % change from baseline at follow-up in all Arms/groups</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX)</title>
        <description>% change from baseline</description>
        <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX)</title>
          <description>% change from baseline</description>
          <units>% change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.78" spread="18.14"/>
                    <measurement group_id="O2" value="147.12" spread="40.72"/>
                    <measurement group_id="O3" value="105.06" spread="11.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.67" spread="32.24"/>
                    <measurement group_id="O2" value="180.27" spread="44.45"/>
                    <measurement group_id="O3" value="148.45" spread="36.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.19" spread="18.88"/>
                    <measurement group_id="O2" value="167.01" spread="47.01"/>
                    <measurement group_id="O3" value="165.16" spread="40.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.39" spread="23.89"/>
                    <measurement group_id="O2" value="167.27" spread="25.30"/>
                    <measurement group_id="O3" value="174.58" spread="47.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.09" spread="26.72"/>
                    <measurement group_id="O2" value="239.51" spread="49.42"/>
                    <measurement group_id="O3" value="230.42" spread="54.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109.27" spread="29.39"/>
                    <measurement group_id="O2" value="283.15" spread="65.65"/>
                    <measurement group_id="O3" value="267.89" spread="104.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110.61" spread="30.92"/>
                    <measurement group_id="O2" value="368.31" spread="93.63"/>
                    <measurement group_id="O3" value="140.58" spread="78.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-35.73" spread="11.53"/>
                    <measurement group_id="O2" value="-8.60" spread="11.15"/>
                    <measurement group_id="O3" value="-41.33" spread="20.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>The reported p-value corresponds to % change (increase) from baseline in all Arms/groups at Days 2-8.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The reported p-value corresponds to the % change from baseline at follow-up in all Arms/groups</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amino-terminal Peptides of Procollagen 1 (P1NP)</title>
        <description>% change from baseline</description>
        <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Amino-terminal Peptides of Procollagen 1 (P1NP)</title>
          <description>% change from baseline</description>
          <units>% change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.05" spread="4.95"/>
                    <measurement group_id="O2" value="-17.49" spread="5.93"/>
                    <measurement group_id="O3" value="-23.88" spread="6.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.83" spread="2.78"/>
                    <measurement group_id="O2" value="-30.44" spread="7.10"/>
                    <measurement group_id="O3" value="-37.77" spread="6.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12.16" spread="0.57"/>
                    <measurement group_id="O2" value="-25.66" spread="9.55"/>
                    <measurement group_id="O3" value="-39.44" spread="4.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.63" spread="2.27"/>
                    <measurement group_id="O2" value="-21.27" spread="8.01"/>
                    <measurement group_id="O3" value="-45.04" spread="3.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.42" spread="5.07"/>
                    <measurement group_id="O2" value="-31.71" spread="7.50"/>
                    <measurement group_id="O3" value="-39.55" spread="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12.59" spread="6.17"/>
                    <measurement group_id="O2" value="-30.98" spread="8.87"/>
                    <measurement group_id="O3" value="-39.88" spread="2.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-16.03" spread="5.03"/>
                    <measurement group_id="O2" value="-36.60" spread="9.64"/>
                    <measurement group_id="O3" value="-38.53" spread="3.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.12" spread="2.29"/>
                    <measurement group_id="O2" value="0.60" spread="9.58"/>
                    <measurement group_id="O3" value="46.67" spread="17.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>the reported p-value corresponds to % decrease compared to baseline at Days 2-8 in all Arms/groups</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>0.01</p_value>
            <p_value_desc>the reported p-value corresponds to % change from baseline at the follow-up visit in all Arms/groups</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bone Specific Alkaline Phosphatase (BSAP)</title>
        <description>% change from baseline</description>
        <time_frame>Baseline, Daily, and 1 week follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Bone Specific Alkaline Phosphatase (BSAP)</title>
          <description>% change from baseline</description>
          <units>% change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12.53" spread="8.60"/>
                    <measurement group_id="O2" value="-1.17" spread="4.10"/>
                    <measurement group_id="O3" value="24.54" spread="7.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.35" spread="4.84"/>
                    <measurement group_id="O2" value="-1.44" spread="3.07"/>
                    <measurement group_id="O3" value="34.77" spread="6.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.82" spread="1.58"/>
                    <measurement group_id="O2" value="-3.79" spread="4.65"/>
                    <measurement group_id="O3" value="19.49" spread="8.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.33" spread="0.33"/>
                    <measurement group_id="O2" value="-9.64" spread="4.73"/>
                    <measurement group_id="O3" value="13.61" spread="9.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.16" spread="9.32"/>
                    <measurement group_id="O2" value="-10.88" spread="4.04"/>
                    <measurement group_id="O3" value="9.02" spread="8.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.91" spread="10.38"/>
                    <measurement group_id="O2" value="-16.78" spread="2.58"/>
                    <measurement group_id="O3" value="9.86" spread="4.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.80" spread="8.66"/>
                    <measurement group_id="O2" value="-14.01" spread="3.72"/>
                    <measurement group_id="O3" value="15.27" spread="11.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.25" spread="2.70"/>
                    <measurement group_id="O2" value="6.16" spread="3.81"/>
                    <measurement group_id="O3" value="18.23" spread="2.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>0.001</p_value>
            <p_value_desc>the reported p-value correspond to the decrease compared to baseline over time in the PTHrP 4 pmol group.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>.01</p_value>
            <p_value_desc>the reported p=value corresponds to % change compared to baseline at follow-up in all Arms/groups</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parathyroid Hormone (1-84)</title>
        <description>pg/ml</description>
        <time_frame>Baseline and Daily</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Parathyroid Hormone (1-84)</title>
          <description>pg/ml</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.97" spread="2.86"/>
                    <measurement group_id="O2" value="30.70" spread="5.56"/>
                    <measurement group_id="O3" value="48.27" spread="15.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.47" spread="1.48"/>
                    <measurement group_id="O2" value="7.82" spread="1.50"/>
                    <measurement group_id="O3" value="3.60" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.43" spread="3.65"/>
                    <measurement group_id="O2" value="5.23" spread="1.75"/>
                    <measurement group_id="O3" value="3.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.77" spread="3.24"/>
                    <measurement group_id="O2" value="7.88" spread="3.21"/>
                    <measurement group_id="O3" value="3.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.37" spread="5.10"/>
                    <measurement group_id="O2" value="7.54" spread="1.80"/>
                    <measurement group_id="O3" value="3.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.13" spread="5.88"/>
                    <measurement group_id="O2" value="6.57" spread="2.24"/>
                    <measurement group_id="O3" value="3.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.40" spread="4.03"/>
                    <measurement group_id="O2" value="5.67" spread="1.20"/>
                    <measurement group_id="O3" value="3.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.60" spread="3.58"/>
                    <measurement group_id="O2" value="3.00" spread="0.00"/>
                    <measurement group_id="O3" value="3.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.37" spread="5.18"/>
                    <measurement group_id="O2" value="31.60" spread="2.63"/>
                    <measurement group_id="O3" value="44.20" spread="10.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>the reported p-values correspond to the decrease compared to baseline in all arms/groups at Days 2-8</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fractional Excretion of Calcium</title>
        <description>% calculated from daily second morning void</description>
        <time_frame>daily</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>PTHrP(1-36) 4 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O3">
            <title>Group 3</title>
            <description>PTHrP(1-36) 5 picomoles/kg/hr for one week</description>
          </group>
          <group group_id="O4">
            <title>Group 4</title>
            <description>PTHrP(1-36) 6 picomoles/kg/hr for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Fractional Excretion of Calcium</title>
          <description>% calculated from daily second morning void</description>
          <units>% of filtered load</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.93" spread="0.91"/>
                    <measurement group_id="O2" value="2.57" spread="0.73"/>
                    <measurement group_id="O3" value="2.38" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.31" spread="0.59"/>
                    <measurement group_id="O2" value="2.26" spread="0.46"/>
                    <measurement group_id="O3" value="4.11" spread="2.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="0.51"/>
                    <measurement group_id="O2" value="2.85" spread="0.61"/>
                    <measurement group_id="O3" value="3.27" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.57" spread="0.25"/>
                    <measurement group_id="O2" value="2.79" spread="0.76"/>
                    <measurement group_id="O3" value="2.14" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.05" spread="0.70"/>
                    <measurement group_id="O2" value="2.05" spread="0.46"/>
                    <measurement group_id="O3" value="3.12" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.37" spread="0.67"/>
                    <measurement group_id="O2" value="2.75" spread="0.25"/>
                    <measurement group_id="O3" value="5.42" spread="2.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.72" spread="0.28"/>
                    <measurement group_id="O2" value="3.94" spread="0.38"/>
                    <measurement group_id="O3" value="4.13" spread="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The study was designed as a standard dose-escalation study, dose-finding pilot study. The primary outcome measures were safety (hypercalcemia, hypophosphatemia and symptoms/hemodynamic measurements). A modified Fibronacci dose-escalation scheme was employed.</non_inferiority_desc>
            <p_value>.002</p_value>
            <p_value_desc>the reported p-value corresponds to the increase comapred to baseline over time (days 2-8) in the PTHrP 4 pmol group</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The level of statistical significance was set at .05 (two-tailed)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Subjects were systematically assessed every 8 hours for adverse events</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
          <description>PTHrP(1-36) 2 picomoles/kg/hr for one week.</description>
        </group>
        <group group_id="E2">
          <title>Group 2</title>
          <description>PTHrP(1-36) 4 picomoles/kg/hr for one week.</description>
        </group>
        <group group_id="E3">
          <title>Group 3</title>
          <description>PTHrP(1-36) 5 picomoles/kg/hr for one week.</description>
        </group>
        <group group_id="E4">
          <title>Group 4</title>
          <description>PTHrP(1-36) 6 picomoles/kg/hr for one week.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>hypercalcemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>lightheaded</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small number of subjects in each group Study limited to Caucasians Only one timepoint for follow-up was measure Study did not include saline infused controls</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Mara J Horwitz, MD</name_or_title>
      <organization>University of Pittsburgh</organization>
      <phone>4126922848</phone>
      <email>horwitz@pitt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

